Abstract

This IDC Presentation summarizes the latest major European policy, regulatory, and development strategy news and initiatives shaping the technology landscape in the European life sciences market. As IDC Health Insights continues to provide in-depth research coverage of the European life sciences industry, this document aims to help life sciences organizations and their technology vendors stay aligned with the fast-evolving policy, funding, and regulatory developments in Europe to inform their digital initiatives and business strategies and capitalize on favorable opportunities.

"The latest policy and regulatory initiatives in the European life sciences industry have evolved around fostering secondary uses of health data, enabling a favorable environment for clinical trials, enhancing pharmacovigilance systems, and strengthening life sciences supply chain resilience for effective crisis preparedness and response."— Research Manager Nino Giguashvili, IDC Health Insights Europe

Coverage